They really know how to spend our money...4 gold stars!
Can anyone explain the "11M interest for the DFA"? I thought that if and only the drug is commercialized, OPT would "simply" need to pay back 4X the funding agreement over a fixed number of years.
I think they've confused cents with dollars; the loss per share is listed as US$10.82, but I think it should be 10 cents.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| OPT (ASX) Chart |
Day chart unavailable